Clinical Trial Update: Curcumin and EGCG Supplementation to Improve Serum BDNF and Mood Disturbance [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 clinical trial sponsored by Auburn University is investigating whether curcumin and epigallocatechin gallate (EGCG) supplementation can improve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mood Disorders

Drugs mentioned

• Curcumin (curcumin)
• Epigallocatechin Gallate (EGCG) (epigallocatechin gallate)

Snippet

Sponsor: Auburn University | Conditions: Mood Disturbance | EARLY_Phase 1 | Status: RECRUITING